New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 13, 2014
11:37 EDTREY, OPEN, ARWR, TSRA, MHFI, SYY, EXPR, GPI, GESHigh option volume stocks
High option volume stocks: REY OPEN URA ARWR TSRA MHFI SYY EXPR GPI GES
News For REY;OPEN;ARWR;TSRA;MHFI;SYY;EXPR;GPI;GES From The Last 14 Days
Check below for free stories on REY;OPEN;ARWR;TSRA;MHFI;SYY;EXPR;GPI;GES the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 14, 2014
06:07 EDTGESGuess initiated with a Buy at Wunderlich
Subscribe for More Information
August 13, 2014
10:33 EDTARWROptions with decreasing implied volatility
Options with decreasing implied volatility: RPTP ARWR ZU ICPT MNKD UBNT OLED RAX UVXY VNDA
10:20 EDTARWRHigh option volume stocks
Subscribe for More Information
09:15 EDTARWROn The Fly: Pre-market Movers
Subscribe for More Information
07:56 EDTARWRArrowhead should trade up on Hep B data, says RBC Capital
RBC Capital said Arrowhead's initial top-line Phase IIa data showed good knockdown of s-antigen, durability, and safety. The firm expects shares to trade up on the news and notes doctors say increased doses and time could lead to higher cures of Hep B. Shares are Outperform rated.
07:36 EDTARWRArrowhead shares recommended after ARC-520 data at Deutsche Bank
Subscribe for More Information
06:35 EDTARWRArrowhead shares likely weak on lack of data, says Piper Jaffray
Piper Jaffray expects shares of Arrowhead to be under pressure following the company's Q3 results given the lack of data for ARC-520 for the treatment of hepatitis-B virus infection. Piper keeps an Overweight rating on the stock with a $24 price target.
August 12, 2014
19:02 EDTARWROn The Fly: After Hours Movers
Subscribe for More Information
16:16 EDTARWRArrowhead Research provides update on phase 2a study of ARC-520
Arrowhead Research completed its dosing of 1mg/kg and 2mg/kg dose cohorts. The company's initial blinded data suggest that the magnitude of HBsAg knockdown is similar to non-human primate studies, including the chronically infected chimpanzee reported on previously. ARC-520 continues to be well tolerated, with no dropouts or serious adverse events reported. The overall rate of AEs has been lower in the phase 2a than in the phase 1 normal volunteer study and safety labs continue to show no indication of end organ toxicity. The company received IRB and DSMB approvals to proceed and began enrolling an additional dose cohort at 3 mg/kg in the Phase 2a patient study.
16:13 EDTARWRArrowhead Research reports Q3 EPS (22c), consensus (22c)
Total operating expenses for the quarter were $12.7M, compared to $6.4M for the quarter ended June 30, 2013. The company’s cash and investments of cash were $188.5M at June 30.
11:10 EDTGPIHigh option volume stocks
High option volume stocks: ACM KATE ARO TKMR ODP ICPT GPI FENG LINTA NDLS
August 11, 2014
16:31 EDTGPIGlenview Capital reports 6.24% passive stake in Group 1 Automotive
11:02 EDTSYYSysco continues to look at transactions
Says "fairly occupied" right now planning for U.S. Foods integration. Says will be "a little difficult" to do deals in the U.S. while it works to get U.S. Foods deal approved.
10:23 EDTSYYSysco says long-term sales growth guidance "reasonable"
Says guidance includes inflation, excludes U.S. Foods deal. Sees inflation returning to more modest historic levels. Comments made on the Q4 earnings conference call.
09:57 EDTSYYSysco sees long-term sales growth 4%-6% annually
Subscribe for More Information
09:50 EDTSYYSysco sees U.S. Food merger closing in late Q3 or in Q4
Sysco said in slides that will be presented on its Q4 earnings conference call that FTC discussions continue to be productive. Remains on track to achieve Business Transformation financial target for FY15.
08:05 EDTSYYSysco reports Q4 adjusted EPS 50c, consensus 50c
Reports Q4 revenue $12.3B, consensus $12.14B.
August 8, 2014
06:28 EDTARWRArrowhead Research volatility elevated
Subscribe for More Information
August 7, 2014
15:17 EDTSYYSysco August volatility elevated into Q4 and outlook
Subscribe for More Information
13:14 EDTSYYSysco now sees US Foods merger closing late Q3 or during Q4
Sysco said earlier today that the FTC's review of the Sysco-US Foods proposed merger continues to proceed as expected. It is anticipated that the transaction will close either late in Q3 or during Q4 of this calendar year.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use